Details werden geladen...
Sun will require HC nod for Semaglutide tablet launch - The Economic Times
The Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisks patent infringement plea. The court also sought Sun Pharmas response to Novo Nordisks claim of patent protection for the tablet formulation.
Ähnliche Seiten
Delhi HC directs Sun Pharma to take permission before launching semaglutide | Company Business News
https://www.livemint.com/companies/delhi-hc-directs-sun-pharma-to-take-permission-before-launching-semaglutide-weight-loss-drug-ozempic-wegovy-11786450955811.html
Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun Pharma - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-hc-allows-intas-to-sell-cancer-drug-bevatas-sets-aside-order-favouring-sun-pharma/articleshow/131449013.cms